PHARMAS
Early on and exact selection of patients, sub-group identification and ongoing adaptative monitoring are crucial to clinical trial success. Qynapse is changing drug targeting and efficacy measurement.
PHARMAS
Early on and exact selection of patients, sub-group identification and ongoing adaptative monitoring are crucial to clinical trial success. Qynapse is changing drug targeting and efficacy measurement.
PHARMAS
Early on and exact selection of patients, sub-group identification and ongoing adaptative monitoring are crucial to clinical trial success. Qynapse is changing drug targeting and efficacy measurement.
Data protection is imperative. Our security partner provides a safe global network for the collection, de-identification and sharing of medical images for real-time data access and transfer.
Implementation made easy. Our vendor-neutral software is easily integrated into all clinical centers and is compatible with any PACS providers, for a simple and scalable solution.
Safe, secure, reliable. Qynapse is ISO13485:2016 certified and QyScore® is a class IIa medical device software.
GETTING
STARTED
Seamless integration with trial players and smooth data delivery to all stakeholders
GETTING
STARTED
Seamless integration with trial players and smooth data delivery to all stakeholders
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
Qynapse (Paris)
130, rue de Lourmel
75015 Paris – France
contact[@]qynapse.com
This website uses cookies. By continuing to browse our website, you are agreeing to our use of cookies.
For more information, see our privacy policy